Wird geladen...
Immune checkpoint blockade and biomarkers of clinical response in non–small cell lung cancer
Immunotherapy with PD‐1 and PD‐L1 inhibitors has revolutionized the treatment for patients with NSCLC the last years with increased overall survival and in particular increased number of long‐time survivors in patients with metastatic disease. It is now a treatment of choice for patients with distan...
Gespeichert in:
| Veröffentlicht in: | Scand J Immunol |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
John Wiley and Sons Inc.
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7757202/ https://ncbi.nlm.nih.gov/pubmed/33015859 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/sji.12980 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|